Claims
- 1. A process for preparing a pharmaceutical for oral delivery in a pharmaceutically acceptable liquid carrier, comprising:
at the time of use, adding to a pharmaceutically acceptable liquid carrier a solid unit dosage form, said solid unit dosage form comprising a substrate that disintegrates in the liquid carrier, and at least one particulate pharmaceutically active material deposited on the substrate as a layer distinct from the substrate, said at least one pharmaceutically active material being present on said substrate in a pharmaceutically effective amount whereby said at least one pharmaceutically active material can be orally delivered in the liquid carrier in a pharmaceutically effective dosage without measuring the quantity of liquid carrier at the time of use.
- 2. A product comprising:
a package; a plurality of solid unit dosage forms comprising a substrate that is soluble in a pharmaceutically acceptable liquid and at least one particulate pharmaceutically active material deposited on the substrate as a layer distinct from the substrate, said at least one pharmaceutically active material being present on said substrate in a pharmaceutically effective amount; and instruction to add the solid unit dosage form, at the time of use, to a pharmaceutically acceptable liquid carrier for oral delivery in said carrier.
- 3. The product of claim 2 wherein said at least one pharmaceutically active material is present on said substrate in a dosage suitable for administration to children.
- 4. The product of claim 2 wherein said layer of said at least one pharmaceutically active material is essentially free of materials other than pharmaceutically active material.
- 5. The product of claim 2 wherein said at least one pharmaceutically active material is present on said substrate in a dosage suitable for administration to a geriatric patient.
- 6. The process of claim 1 wherein said pharmaceutically acceptable liquid carrier is water.
- 7. The process of claim 1 wherein said substrate is selected from the group consisting of gelatin, hydroxypropylmethylcellulose, hydroxypropylcellulose, polyvinyl alcohol, polyethylene oxide, polyvinylpyrrolidone, sodium alginate, carboxymethylcellulose, and agar.
- 8. The product of claim 2 wherein said substrate is selected from the group consisting of gelatin, hydroxypropylmethylcellulose, hydroxypropylcellulose, polyvinyl alcohol, polyethylene oxide, polyvinylpyrrolidone, sodium alginate, carboxymethylcellulose, and agar.
- 9. The process of claim 1 wherein said pharmaceutically active material is an antibiotic.
- 10. The process of claim 1 wherein said pharmaceutically active material is an anti-viral agent.
- 11. The process of claim 1 wherein said pharmaceutically active material is an anti-fungal agent.
- 12. The product of claim 2 wherein said pharmaceutically active material is an antibiotic.
- 13. The product of claim 2 wherein said pharmaceutically active material is an anti-viral agent.
- 14. The product of claim 2 wherein said pharmaceutically active material is an anti-fungal agent.
Parent Case Info
[0001] This application claims the priority of provisional application Serial No. 60/101,897, filed Sep. 25, 1998.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60101897 |
Sep 1998 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09404412 |
Sep 1999 |
US |
Child |
10401350 |
Mar 2003 |
US |